136 related articles for article (PubMed ID: 37581651)
21. Association between normal tension glaucoma and the risk of Alzheimer's disease: a nationwide population-based cohort study in Taiwan.
Chen YY; Lai YJ; Yen YF; Shen YC; Wang CY; Liang CY; Lin KH; Fan LW
BMJ Open; 2018 Nov; 8(11):e022987. PubMed ID: 30397009
[TBL] [Abstract][Full Text] [Related]
22. Risk of retinopathy in women with pregnancy-induced hypertension: a nationwide population-based cohort study of 9-year follow-up after delivery.
Lee H; Yang SW; Kim Y; Shin H; Seo YS; Oh MJ; Choi S; Cho GJ; Hwang HS
Am J Obstet Gynecol MFM; 2023 Jul; 5(7):100985. PubMed ID: 37119970
[TBL] [Abstract][Full Text] [Related]
23. Increased risk for central serous chorioretinopathy in nephrotic syndrome patients: A population-based cohort study.
Lee LC; Wu TJ; Huang KH; Chen YH; Chen JT; Chung CH; Chien WC; Chen CL
J Chin Med Assoc; 2021 Nov; 84(11):1060-1069. PubMed ID: 34320516
[TBL] [Abstract][Full Text] [Related]
24. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients.
Ersoz MG; Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Br J Ophthalmol; 2019 Jun; 103(6):725-729. PubMed ID: 30002072
[TBL] [Abstract][Full Text] [Related]
25. Is normal-tension glaucoma a risk factor for stroke?-A 10-year follow-up study.
Lee MS; Kuo LL; Tan EC; Lee OK
PLoS One; 2017; 12(6):e0179307. PubMed ID: 28628626
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Genetic Characteristics of Pachydrusen in Eyes with Central Serous Chorioretinopathy and General Japanese Individuals.
Takahashi A; Hosoda Y; Miyake M; Miyata M; Oishi A; Tamura H; Ooto S; Yamashiro K; Tabara Y; Matsuda F; Tsujikawa A
Ophthalmol Retina; 2021 Sep; 5(9):910-917. PubMed ID: 33309963
[TBL] [Abstract][Full Text] [Related]
27. Systemic factors associated with central serous chorioretinopathy in Koreans.
Eom Y; Oh J; Kim SW; Huh K
Korean J Ophthalmol; 2012 Aug; 26(4):260-4. PubMed ID: 22870024
[TBL] [Abstract][Full Text] [Related]
28. CILIOCHOROIDAL EFFUSION IN CENTRAL SEROUS CHORIORETINOPATHY.
Terao N; Imanaga N; Wakugawa S; Sawaguchi S; Tamashiro T; Yamauchi Y; Koizumi H
Retina; 2022 Apr; 42(4):730-737. PubMed ID: 34907128
[TBL] [Abstract][Full Text] [Related]
29. Risk of developing open-angle glaucoma in patients with carotid artery stenosis: A nationwide cohort study.
Chou CC; Hsu MY; Lin CH; Lin CC; Wang CY; Shen YC; Wang IJ
PLoS One; 2018; 13(4):e0194533. PubMed ID: 29684030
[TBL] [Abstract][Full Text] [Related]
30. Temporal Association between Topical Ophthalmic Corticosteroid and the Risk of Central Serous Chorioretinopathy.
Chang YS; Weng SF; Wang JJ; Jan RL
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33348672
[TBL] [Abstract][Full Text] [Related]
31. Increased incidence of peptic ulcer disease in central serous chorioretinopathy patients: a population-based retrospective cohort study.
Chen SN; Lian I; Chen YC; Ho JD
Retina; 2015 Feb; 35(2):231-7. PubMed ID: 25099218
[TBL] [Abstract][Full Text] [Related]
32. Relationship between Obstructive Sleep Apnea and Central Serous Chorioretinopathy: A Health Insurance Database Study.
Lee CY; Yeung L; Kuan Jen C; Sun MH; Sun CC
Ophthalmic Epidemiol; 2022 Jun; 29(3):302-309. PubMed ID: 34016006
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of open-angle glaucoma among patients with diabetes mellitus: a 10-year follow-up nationwide cohort study.
Rim TH; Lee SY; Bae HW; Seong GJ; Kim SS; Kim CY
Acta Ophthalmol; 2018 Dec; 96(8):e1025-e1030. PubMed ID: 29862632
[TBL] [Abstract][Full Text] [Related]
34. RISK OF RETINAL VEIN OCCLUSION WITH CENTRAL SEROUS CHORIORETINOPATHY.
Chang YS; Chang C; Weng SF; Wang JJ; Jan RL
Retina; 2016 Apr; 36(4):798-804. PubMed ID: 26441266
[TBL] [Abstract][Full Text] [Related]
35. Increased risk of central serous chorioretinopathy following end-stage renal disease: A nationwide population-based study.
Chang YS; Weng SF; Wang JJ; Jan RL
Medicine (Baltimore); 2019 Mar; 98(11):e14859. PubMed ID: 30882685
[TBL] [Abstract][Full Text] [Related]
36. A multicentre study of the risk factors associated with recurrence of central serous chorioretinopathy.
Zhou X; Komuku Y; Araki T; Hozumi K; Terasaki H; Miki A; Kuwayama S; Niki M; Matsubara H; Kinoshita T; Nishi T; Gomi F
Acta Ophthalmol; 2022 Dec; 100(8):e1729-e1736. PubMed ID: 35633142
[TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
38. Associations Between Topical Ophthalmic Corticosteroids and Central Serous Chorioretinopathy: A Taiwanese Population-Based Study.
Chang YS; Weng SF; Chang C; Wang JJ; Wang JY; Jan RL
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4083-9. PubMed ID: 26114485
[TBL] [Abstract][Full Text] [Related]
39. Risk of Glaucoma Associated with Components of Metabolic Disease in Taiwan: A Nationwide Population-Based Study.
Chang YW; Sung FC; Tzeng YL; Mou CH; Tien PT; Su CW; Teng YK
Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010564
[TBL] [Abstract][Full Text] [Related]
40. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.
Kitzmann AS; Pulido JS; Diehl NN; Hodge DO; Burke JP
Ophthalmology; 2008 Jan; 115(1):169-73. PubMed ID: 18166410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]